Search company, investor...

BaroSense

barosense.com

Founded Year

2001

Stage

Acquired | Acquired

Total Raised

$48.7M

About BaroSense

BaroSense is developing trans-oral medical devices and procedures for addressing obesity and its co-morbidities

Headquarters Location

3698-C Haven Avenue

Redwood City, California, 94063,

United States

650-362-6000

Missing: BaroSense's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BaroSense's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

BaroSense Patents

BaroSense has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/11/2013

1/31/2017

Digestive system surgery, Inedible fungi, Edible fungi, Digestive system procedures, Vacuum

Grant

Application Date

1/11/2013

Grant Date

1/31/2017

Title

Related Topics

Digestive system surgery, Inedible fungi, Edible fungi, Digestive system procedures, Vacuum

Status

Grant

Latest BaroSense News

Boston Scientific : Trademark Application for "BAROSENSE" Filed

Feb 12, 2015

. This application was made available to the public on January 30, 2015 The serial number for this application is 77023343. The international trademark goods and services class code for this trademark application is 010. As submitted by the applicant, this trademark application relates to the following goods and services: Medical apparatus, devices and instruments for use in the treatment of obesity, namely, medical apparatus, devices and instruments used in the reconfiguration of the stomach. The owner/registrar information for this application is: Luke Dohmen

BaroSense Frequently Asked Questions (FAQ)

  • When was BaroSense founded?

    BaroSense was founded in 2001.

  • Where is BaroSense's headquarters?

    BaroSense's headquarters is located at 3698-C Haven Avenue, Redwood City.

  • What is BaroSense's latest funding round?

    BaroSense's latest funding round is Acquired.

  • How much did BaroSense raise?

    BaroSense raised a total of $48.7M.

  • Who are the investors of BaroSense?

    Investors of BaroSense include Boston Scientific, Delphi Ventures, Frazier Healthcare Partners, RWI Ventures, Invesco Private Capital and 6 more.

  • Who are BaroSense's competitors?

    Competitors of BaroSense include CardioFocus, BioProtect, GENICON, Surgiquest, nContact Surgical and 11 more.

Compare BaroSense to Competitors

S
Softscope Medical Technologies

Softscope Medical Technologies is developing a medical technology designed to facilitate the performance of endoscopic procedures.

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

T
Therus

Therus is developing the Therus Acoustic Hemostasis System, a medical device designed for rapid, durable, noninvasive sealing of femoral artery access punctures following catheterization-laboratory procedures such as angiography and angioplasty.

CardioFocus Logo
CardioFocus

CardioFocus manufactures medical devices dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF). It's HeartLight Endoscopic Ablation System incorporates a compliant balloon and an endoscope to provide physicians with the capacity to see within the heart and visually direct the application of laser energy to achieve durable pulmonary vein isolation. The company was founded in 1990 and is based in Marlborough, Massachusetts.

M
Mst (Medical Smart Tools)

MST - Medical Smart Tools was founded in 2004 with the mission to develop image guided surgery technology solutions. The Company aims to improve laparoscopic and other minimally invasive surgical procedures and medical staff effectiveness, thus increasing hospital efficiencies, reducing surgical costs, and improving patient outcomes. MST is working within NGT, a private technological incubator in Nazareth, Israel. MST presents the market with a smart disposable Robotic Arm camera holder for laparoscopy, based on advanced image technology. The system is comprised of a computer-controlled mechanism for mechanical camera motivation, intuitive interface between the surgeon and the mechanical system. The company's R&D efforts are spearheaded by a core group of engineers with expertise in image processing, dynamics of mechanisms, multi-link systems and biomechanics. The Company is backed by strong and experienced management and professional medical advisors.

E
Es Vascular

ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.